Deals
Bain Is Exploring €1 Billion Sale of Centrient Pharma
- PE firm working with Citigroup and Jefferies on Centrient sale
- Bain bought Centrien, formerly DSM Sinochem Pharma, in 2018
This article is for subscribers only.
Bain Capital is exploring a sale of Centrient Pharmaceuticals, an antibodies manufacturer that could be valued at as much as €1 billion ($1.1 billion), people familiar with the matter said.
The private equity firm is working with Citigroup Inc. and Jefferies Financial Group Inc. on a possible divestment of Netherlands-based Centrient, according to the people, who asked not to be identified discussing confidential information.